Reckitt Benckiser Group (OTCMKTS:RBGLY) Stock Rating Lowered by Sanford C. Bernstein

Reckitt Benckiser Group (OTCMKTS:RBGLYGet Free Report) was downgraded by Sanford C. Bernstein from a “strong-buy” rating to a “hold” rating in a research report issued on Monday, Zacks.com reports.

Other analysts have also recently issued reports about the stock. Barclays upgraded shares of Reckitt Benckiser Group to a “strong-buy” rating in a research report on Friday, October 4th. Citigroup raised Reckitt Benckiser Group to a “strong-buy” rating in a research note on Tuesday, October 1st. UBS Group raised Reckitt Benckiser Group to a “strong-buy” rating in a research report on Wednesday, September 18th. Finally, JPMorgan Chase & Co. downgraded Reckitt Benckiser Group from an “overweight” rating to a “neutral” rating in a research report on Thursday, August 29th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and three have issued a strong buy rating to the company. According to data from MarketBeat.com, Reckitt Benckiser Group currently has a consensus rating of “Moderate Buy”.

View Our Latest Research Report on RBGLY

Reckitt Benckiser Group Stock Performance

Reckitt Benckiser Group stock opened at $12.89 on Monday. Reckitt Benckiser Group has a 52-week low of $10.24 and a 52-week high of $15.03. The company has a quick ratio of 0.47, a current ratio of 0.69 and a debt-to-equity ratio of 0.97. The firm’s fifty day moving average is $12.22 and its 200 day moving average is $11.56.

About Reckitt Benckiser Group

(Get Free Report)

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.

Featured Articles

Analyst Recommendations for Reckitt Benckiser Group (OTCMKTS:RBGLY)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.